Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
Product: Celebrex
Active Ingredient: Celecoxib 100mg
Dosage Form: Capsule
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturer: Pfizer Pharmaceuticals LLC, Caguas, Puerto Rico
Product: Celebrex
Active Ingredient: Celecoxib 200mg
Dosage Form: Capsule
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturer: Pfizer Pharmaceuticals LLC, Caguas, Puerto Rico
Product: Celebrex
Active Ingredient: Celecoxib 400mg
Dosage Form: Capsule
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturer: Pfizer Pharmaceuticals LLC, Caguas, Puerto Rico
Product: Isentress
Active Ingredient: Raltegravir potassium 434.3mg equivalent to Raltegravir 400mg
Dosage Form: Tablet
New Zealand Sponsor: Merck Sharp & Dohme (New Zealand) Limited
Manufacturers: Merck & Co Inc, Virginia, United States of America
MSD Technology Singapore Pte Limited, Avenue 6, Singapore
Product: Onsenal
Active Ingredient: Celecoxib 200mg
Dosage Form: Capsule
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturer: Pfizer Pharmaceuticals LLC, Caguas, Puerto Rico
Product: Onsenal
Active Ingredient: Celecoxib 400mg
Dosage Form: Capsule
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturer: Pfizer Pharmaceuticals LLC, Caguas, Puerto Rico
Dated this 5th day of February 2010.
ANTHONY HILL, Deputy Director-General, Regulation and Governance Directorate, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).